Veriheal

JANUARY 18, 2024

Cannabis nurses are crucial in bridging the gap between traditional healthcare and emerging cannabis therapies. These nurses also offer valuable insights on integrating cannabis therapies into various healthcare settings, including dispensaries, primary care clinics, and specialized pain management centers. So what does it all mean?

Education 113

Education Therapy Patients Research and Development 113

Cannabis Law Report

FEBRUARY 14, 2023

Marijuana Moment reports Arizona lawmakers have approved a bill in committee to promote research into the medical potential of psilocybin mushrooms for a variety of conditions, which could inform future reforms to more broadly allow access to psychedelic-assisted therapy. Kevin Payne (R), Jennifer […]

Therapy 52

Therapy Safety Legislation Conditions 52

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

MAY 9, 2024

As such, we provide you with a comprehensive guide for veterans using medical cannabis and the various aspects of it, including its usage, accessibility, legal considerations, healthcare options, and available resources. Navigating the complexities surrounding the Veterans Administration and medical cannabis can be daunting.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.”

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

MMJ Recs

JANUARY 24, 2024

Today we’ll take a closer look at the Michigan Medical Marijuana Program, giving Michigan citizens all the info they need about accessing MMJ in the state. The state legalized medical marijuana in 2008, establishing a framework for patients to access cannabis for therapeutic purposes.

Programs 52

Programs Marijuana Access Chronic Pain 52

MMJ Recs

MARCH 20, 2024

Through these specialized services, Maryland dispensaries play a crucial role in providing accessible and quality medical cannabis options to patients statewide. These expansions aim to increase patient access and address supply shortages experienced in the past.

Dispensary 52

Dispensary Programs Access Patients 52

MMJ Recs

MAY 25, 2024

It makes cannabis therapy an option that would help a range of patients who suffer from several medical conditions, thanks to the modulation of the endocannabinoid system (ECS). Overall, by targeting the ECS, cannabis therapy offers a holistic approach to symptom relief for various medical conditions.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

MMJ Recs

APRIL 5, 2024

With cancer care, New York has emerged as a beacon of progress, offering patients access to a holistic approach that includes medical marijuana. Medical marijuana may also enhance the efficacy of conventional cancer therapies, minimize treatment-related side effects, and improve overall treatment outcomes.

Treatment 52

Treatment Marijuana Patients Therapy 52

MMJ Recs

MAY 29, 2024

This program allows individuals with qualifying medical conditions to access marijuana for therapeutic purposes upon obtaining a medical marijuana card. The importance of access to medical marijuana for individuals with qualifying medical conditions cannot be overstated.

Marijuana 52

Marijuana Programs Patients Conditions 52

Veriheal

JUNE 1, 2023

It had passed through the Senate and the Public Safety and Health committees, but the Assembly Appropriations Committee gutted its main provisions. SB 58, on the other hand, needed to pass through only the Public Safety and Health Committee, hence its accelerated progression to the floor. because there is no public hearing.”

Legalization 91

Legalization Decriminalization Legislation Therapy 91

Cannabis Law Report

OCTOBER 13, 2021

But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. Despite overwhelming evidence that psilocybin is misclassified, this barrier restricts research, stifles competition and innovation, and inhibits access. and his conclusion.

Research and Development 52

Research and Development Therapy Access Data 52

Cannabis Law Report

AUGUST 22, 2021

Biotech startup to bring safety and efficacy to the emerging psychedelic industry, brings on University of Michigan Researcher as Chief Science Officer. “The Janus particle technology has immense potential to transform the delivery of psychedelic therapies amid today’s mental health crisis. MIAMI , Aug.

Pharmaceutical 98

Pharmaceutical Medicine Research and Development Therapy 98

MMJ Recs

MARCH 6, 2024

Discover how legalization and regulation have influenced access and usage, and learn about the latest research and medical applications. Conversely, some states opted for more conservative medical-only programs, tightly regulating patient access and product availability.

Marijuana 52

Marijuana Chronic Pain Patients Treatment 52

Veriheal

NOVEMBER 30, 2021

Veriheal does not support illegally consuming therapeutic substances such as psilocybin but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Research and Development 98

Research and Development Therapy Data Treatment 98

Veriheal

JUNE 30, 2023

Researchers say this emphasizes just how important it is that psilocybin therapy be done in a controlled setting with therapy and community-based after-care. The document also addresses study participant safety emphasizing how psychedelics’ psychoactive effects increase the potential for abuse.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? NH resident? OK resident?

Legislation 243

Legislation Patients Decriminalization Access 243

MMJ Recs

MARCH 2, 2024

In Ohio, accessing medical marijuana involves more than just obtaining a prescription; it requires navigating a complex landscape of dispensaries, regulations, and patient expectations. By utilizing the Ohio Medical Marijuana Dispensaries Map, patients can confidently explore their options and access quality medical cannabis products.

Dispensary 52

Dispensary Patients Marijuana Education 52

The Cannigma

JUNE 2, 2023

The government remains steadfast in its commitment to maintaining strict drug laws to ensure public safety. The use of cannabis for medicinal purposes is not permitted, and there are no legal avenues for patients to access cannabis-based medications. Is weed legal in Singapore? No, weed is illegal in Singapore.

Law 52

Law Research and Development Consumption Therapy 52

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. This is the largest trial ever conducted in psilocybin therapy, and it was done amid the lockdowns and challenges of the COVID pandemic. million, or $0.79 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

JANUARY 31, 2022

This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. These doses are produced under Good Agricultural and Collection Practices and tested for potency and impurities to support patient safety and practitioner confidence. investment community.”

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Cannabis Law Report

JANUARY 20, 2022

Emmer is the vice president of the healthcare practice at Field Trip Health , a mental wellness company at the forefront of the scientific re-emergence of psychedelics and psychedelic-enhanced therapies. Emmer is also a co-founder of the Psykia Institute, which works to advance frameworks around integrative holotropic therapies.

Therapy 52

Therapy Research and Development Access Events 52

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . Promising clinical trial results have generated much interest in studying MDMA as a catalyst to therapy for PTSD and related conditions — and an increased demand for pharmaceutical-grade MDMA.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

JULY 24, 2021

“The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

MAY 26, 2022

The OPEN Foundation invites you to the Interdisciplinary Conference on Psychedelic Research this September, featuring the world’s best experts on psychedelic science and therapy. So we need to discuss openly and critically how we can remain balanced and ensure the potential of psychedelics can be optimised without compromising safety.”.

Research and Development 52

Research and Development Therapy Policy Media 52

Cannabis Law Report

APRIL 12, 2019

I am also prescribed pharmacological and non-pharmacological therapies and try to keep a base of exercise and good nutrition. CFAMM’s goal is to support medical cannabis patients, improve their outcomes and enable them to obtain fair and safe access to their medication. Canadian’s for Fair Access to Medical Marijuana .

Access 45

Access Patients Marijuana Medicine 45

Canna Law Blog

DECEMBER 16, 2021

Psilocybin research license, which will allow the testing potency, conducting clinical investigations, researching efficacy and safety, and agricultural research. Psilocybin therapy is a breakthrough avenue for providing people with treatment for these ailments.

Legislation 97

Legislation Treatment Therapy Conditions 97

SpeedWeed

JULY 6, 2021

The Project on Psychedelics Law and Regulation (POPLAR) is a three-year project aiming to “promote safety, innovation, and equity in psychedelics research, commerce, and therapeutics,” the university said in a press release. Professor of Law at Harvard Law School. “By

Policy 52

Policy Law Research and Development Therapy 52

Cannabis Law Report

FEBRUARY 1, 2022

Medical cannabis and psychedelics are being increasingly recognised by health professionals for their superior safety and efficacy compared to conventional pharmaceuticals. However, a sacred place is never empty and radically new therapies emerge quickly, which is what we see happening with psychedelic medicine.

Pharmaceutical 52

Pharmaceutical Medicine Safety Epilepsy 52

Veriheal

AUGUST 24, 2022

Any sales of psychedelic compounds would still be strictly prohibited; however, the initiative would allow for people to offer psychedelic services such as guidance and therapy or for harm reduction or spiritual purposes with or without payment. Not all alternative medicine advocates are in support of the Natural Medicine Health Act, however.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

JANUARY 20, 2022

Emergency access to restricted drugs has been restored by recent regulatory amendments to Health Canada’s Special Access Program (SAP). SAP allows health care professionals to request access to non-marketed drugs and medical devices not yet authorized for sale in Canada, on behalf of a patient. Footnotes. Footnotes.

Access 52

Access Programs Treatment Therapy 52

NORML

JANUARY 11, 2019

Legislation is pending, House Bill 1272, to expand access to medical cannabis in North Dakota. Update : The Criminal Justice and Public Safety Committee will hold an executive session for HB 399 on 1/17 at 11am. Legislation is pending, House Bill 350, to expand medical cannabis access. ND resident? NH resident? NH resident?

Legislation 198

Legislation Decriminalization Hemp Patients 198

Cannabis Law Report

JULY 1, 2021

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency identified psilocybin as a breakthrough for treatment-resistant depression. While psychedelic therapies make their way through the drug development pipeline, seven U.S. The Role of Psychedelics in Healing Trauma.

Law 59

Law Policy Research and Development Clinical Trials 59

TheAnswerPage

JANUARY 11, 2022

For example, most, if not all, states have legalized the use of medical marijuana to treat specific health conditions for which there is no or only poor quality clinical evidence of efficacy and safety. Who monitors their health and the long-term effects of the marijuana therapy?

Patients 98

Patients Education Marijuana Therapy 98

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. This means that U.S. The company initiated the first legal transfer (as deemed by federal law) to the U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Veriheal

OCTOBER 27, 2023

As a result, Thai residents have gained access to many new jobs in cannabis hospitality, retail, and cultivation. Others, meanwhile, fear that these restrictions will drive the industry underground making product regulation and safety all the more difficult. Thailand became the first Asian country to legalize cannabis early last year.

Decriminalization 62

Decriminalization Treatment Therapy Legislation 62

Cannabis Law Report

MAY 18, 2022

With few solutions in sight, there is a growing body of evidence that suggests that psychedelic-assisted therapy could provide a breakthrough in treating countless mental health ailments, such as depression, substance abuse disorders, and PTSD. The clinical evidence for psychedelic assisted therapy is accumulating.

Research and Development 52

Research and Development Therapy Treatment Policy 52